Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
3(33%)
Results Posted
50%(2 trials)

Phase Distribution

Ph phase_3
5
56%
Ph phase_1
4
44%

Phase Distribution

4

Early Stage

0

Mid Stage

5

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
4(44.4%)
Phase 3Large-scale testing
5(55.6%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

9

all time

Status Distribution
Active(5)
Completed(4)

Detailed Status

Completed4
Recruiting3
Not yet recruiting2

Development Timeline

Analytics

Development Status

Total Trials
9
Active
3
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 14 (44.4%)
Phase 35 (55.6%)

Trials by Status

completed444%
not_yet_recruiting222%
recruiting333%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DRUG
Total Trials
9